Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.39 |
| ▸ | TTR | P02766 | 2/20 | 0.36 |
| ▸ | NECTIN4 | Q96NY8 | 1/20 | 0.31 |
| ▸ | SSTR2 | P30874 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | AKT1 | P31749 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21781864 | 0.96 | CYP3A4 (0.45) | CYP3A4FOLH1TTRNECTIN4SSTR2 | |
| SCHEMBL21781904 | 0.94 | CYP3A4 (0.41) | CYP3A4FOLH1TTRNECTIN4SSTR2 | |
| SCHEMBL21781764 | 0.92 | CYP3A4 (0.43) | CYP3A4FOLH1TTRNECTIN4AKT1 | |
| SCHEMBL22068537 | 0.91 | CYP3A4 (0.49) | CYP3A4FOLH1TTRNECTIN4SSTR2 | |
| SCHEMBL21782058 | 0.89 | CYP3A4 (0.44) | CYP3A4FOLH1TTRNECTIN4OPRD1 | |
| SCHEMBL21782105 | 0.87 | CYP3A4 (0.52) | CYP3A4FOLH1TTRNECTIN4SSTR2 | |
| SCHEMBL21781836 | 0.87 | CYP3A4 (0.52) | CYP3A4FOLH1TTRNECTIN4SSTR2 | |
| SCHEMBL21781866 | 0.86 | CYP3A4 (0.47) | CYP3A4FOLH1TTRNECTIN4SSTR2 | |
| SCHEMBL21781950 | 0.86 | CYP3A4 (0.46) | CYP3A4FOLH1TTRSSTR2OPRD1 | |
| SCHEMBL24136520 | 0.86 | CYP3A4 (0.46) | CYP3A4FOLH1TTRNECTIN4SSTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3617221-A1 | CYTOTOXIN AND CONJUGATE, USES OF SAME, AND PREPARATION METHOD THEREFOR | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (CN) | 2020-03-04 | — | — | EP | disclosed |